512 related articles for article (PubMed ID: 11579707)
1. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Hoffman GS; Cid MC; Hellmann DB; Guillevin L; Stone JH; Schousboe J; Cohen P; Calabrese LH; Dickler H; Merkel PA; Fortin P; Flynn JA; Locker GA; Easley KA; Schned E; Hunder GG; Sneller MC; Tuggle C; Swanson H; Hernández-Rodríguez J; Lopez-Soto A; Bork D; Hoffman DB; Kalunian K; Klashman D; Wilke WS; Scheetz RJ; Mandell BF; Fessler BJ; Kosmorsky G; Prayson R; Luqmani RA; Nuki G; McRorie E; Sherrer Y; Baca S; Walsh B; Ferland D; Soubrier M; Choi HK; Gross W; Segal AM; Ludivico C; Puechal X;
Arthritis Rheum; 2002 May; 46(5):1309-18. PubMed ID: 12115238
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.
Seror R; Baron G; Hachulla E; Debandt M; Larroche C; Puéchal X; Maurier F; de Wazieres B; Quéméneur T; Ravaud P; Mariette X
Ann Rheum Dis; 2014 Dec; 73(12):2074-81. PubMed ID: 23897775
[TBL] [Abstract][Full Text] [Related]
5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Mahr AD; Jover JA; Spiera RF; Hernández-García C; Fernández-Gutiérrez B; Lavalley MP; Merkel PA
Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
[TBL] [Abstract][Full Text] [Related]
8. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
Strand V; Dimonaco S; Tuckwell K; Klearman M; Collinson N; Stone JH
Arthritis Res Ther; 2019 Feb; 21(1):64. PubMed ID: 30786937
[TBL] [Abstract][Full Text] [Related]
10. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
Langford CA; Cuthbertson D; Ytterberg SR; Khalidi N; Monach PA; Carette S; Seo P; Moreland LW; Weisman M; Koening CL; Sreih AG; Spiera R; McAlear CA; Warrington KJ; Pagnoux C; McKinnon K; Forbess LJ; Hoffman GS; Borchin R; Krischer JP; Merkel PA;
Arthritis Rheumatol; 2017 Apr; 69(4):837-845. PubMed ID: 28133925
[TBL] [Abstract][Full Text] [Related]
12. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.
Les I; Pijoán JI; Rodríguez-Álvarez R; Ruiz-Irastorza G; Martínez-Berriotxoa A
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-90-7. PubMed ID: 26016756
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate treatment in the management of giant cell arteritis.
Hernández-García C; Soriano C; Morado C; Ramos P; Fernández-Gutiérrez B; Herrero M; Bañares A; Jover JA
Scand J Rheumatol; 1994; 23(6):295-8. PubMed ID: 7801052
[TBL] [Abstract][Full Text] [Related]
15. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
Kupersmith MJ; Langer R; Mitnick H; Spiera R; Spiera H; Richmond M; Paget S
Br J Ophthalmol; 1999 Jul; 83(7):796-801. PubMed ID: 10381666
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Villiger PM; Adler S; Kuchen S; Wermelinger F; Dan D; Fiege V; Bütikofer L; Seitz M; Reichenbach S
Lancet; 2016 May; 387(10031):1921-7. PubMed ID: 26952547
[TBL] [Abstract][Full Text] [Related]
17. Trial of Tocilizumab in Giant-Cell Arteritis.
Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N
N Engl J Med; 2017 Jul; 377(4):317-328. PubMed ID: 28745999
[TBL] [Abstract][Full Text] [Related]
18. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
Baughman RP; Winget DB; Lower EE
Sarcoidosis Vasc Diffuse Lung Dis; 2000 Mar; 17(1):60-6. PubMed ID: 10746262
[TBL] [Abstract][Full Text] [Related]
20. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.
Hayreh SS; Zimmerman B
Ophthalmologica; 2003; 217(4):239-59. PubMed ID: 12792130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]